ATB — Antibiotice SA Balance Sheet
0.000.00%
- RON1.40bn
- RON1.53bn
- RON675.01m
Annual balance sheet for Antibiotice SA, fiscal year end - December 31st, RON millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 6.33 | 2.11 | 1.73 | 1.81 | 2.68 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 257 | 274 | 195 | 234 | 298 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 375 | 385 | 324 | 401 | 475 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 468 | 481 | 497 | 692 | 749 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 863 | 895 | 856 | 1,139 | 1,279 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 187 | 199 | 135 | 190 | 235 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 286 | 290 | 215 | 292 | 385 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 577 | 605 | 641 | 847 | 894 |
Total Liabilities & Shareholders' Equity | 863 | 895 | 856 | 1,139 | 1,279 |
Total Common Shares Outstanding |